Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Interview with Dr. Bieber

<< Previous

Bullboard Posts

Next >>

Comment by Pareto8020on Jun 24, 2022 6:54am

172 Views

Post# 34779486

RE:Interview with Dr. Bieber

Sounds like he is doing what Howard should have done years ago. Definitely sounds like more than an "Advisor" the way he talks in the interview.

Everything he says seems to be right on the money and I like the fact he sounds like he is going to start the restructuring asap. First part of the restructure - let Howard go back to solely being a Doctor and get a competent experienced CEO to steer the ship to the next level and listing.

<< Previous

Bullboard Posts

Next >>

AI companies to invest in